Integration of a glutamine metabolism-based prognostic signature and a synergistic nanotherapeutic strategy targeting metabolic vulnerabilities in prostate cancer.

Discov Oncol · 2026 · PMC13222916 · PMID 41999530

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Scatter plots illustrated a clear trend where an increasing risk score correlated with a higher incidence of disease progression events (Fig. 3 E, F).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.